Table 4 In vitro cartilage degradation, biomarkers and cytokine profile.
Outcome | Low glucosinolate Mean (95%CI) | High glucosinolate Mean (95%CI) | p-value |
---|---|---|---|
Cartilage matrix degradation | |||
n | 19 | 15 | Â |
Glycosaminoglycan (% loss) | 23.72 (19.58 to 27.87) | 25.68 (21.21 to 30.14) | 0.50 |
Hydroxyproline (% loss) | 0.71 (0.47 to 0.96) | 0.77 (0.50 to 1.03) | 0.65 |
Biomarkers | |||
n | 20 | 17 | Â |
hsCRP (fold change) | −5.48 (−16.02 to 5.05) | −5.49 (−26.90 to 15.93) | 0.33 |
Col2-1 (fold change) | 4.41 (−1.02 to 9.83) | 13.21 (−11.85 to 38.27) | 0.44 |
Cytokine protein expression | |||
n | 19 | 17 | Â |
Interleukin 6 (pg/ml) | 84.54 (64.36 to 104.7) | 70.42 (53.08 to 87.76) | 0.25 |
Interleukin 8 (pg/ml) | 46.62 (30.00 to 63.23) | 36.50 (26.94 to 46.07) | 0.45 |
Interleukin 1 (pg/ml) | 36.80 (36.59 to 37.00) | 36.98 (36.72 to 37.25) | 0.25 |
Tumor necrosis factor (pg/ml) | 39.03 (38.70 to 39.37) | 39.36 (39.13 to 39.60) | 0.10 |
Chemokine (C-C Motif) ligand 5 (pg/ml) | 54.04 (43.39 to 64.69) | 66.80 (31.05 to 102.6) | 0.68 |